Egalet Corp (NASDAQ:EGLT) shares are under pressure following the news that the maker received a complete response letter (CRL) from the FDA regarding the prior approval …
Egalet Corp (NASDAQ:EGLT) shares were sent on a close to 13% rise today after the firm announced this morning that its pipeline drug Egalet-002, …
Egalet Corp (NASDAQ:EGLT) announced yesterday that the FDA had given them notice that they would not be meeting their PDUFA data of Oct …
Biotechnology companies are kicking of pipeline trials for 2016. Analysts weigh in on Merrimack Pharmaceuticals Inc (NASDAQ:MACK) and Egalet Corp (NASDAQ:EGLT) in light …
